Sarcoidosis Clinical Trial
Official title:
Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis
Sarcoidosis is a benign, inflammatory condition which will typically involve the lungs and lymph glands in the chest. Diagnosis is often confirmed with bronchoscopic biopsy. A new method of performing bronchoscopic biopsy of lymph glands in the chest has now been developed which uses real-time endobronchial ultrasonography to better locate the lymph glands. While this technique has been proven to be effective in the diagnosis and staging of lung malignancy, its sensitivity for the diagnosis of sarcoidosis is unclear as smaller samples are obtained compared to the standard approach. This study will aim to randomize 50 patients with a clinical suspicion of sarcoidosis to standard biopsy vs. endobronchial ultrasound guided biopsy of the mediastinal lymph glands in order to compare the sensitivity of these tests for sarcoidosis.
Sarcoidosis is a benign, inflammatory condition which will typically involve the lungs and
mediastinal lymph nodes. The diagnosis of sarcoidosis is usually confirmed with tissue
biopsy, especially if patients in whom treatment with corticosteroids is required.
Asymptomatic patients not requiring treatment may not require biopsy, although this is
commonly performed because of patient's preference in confirming the diagnosis and concerns
about other diagnostic possibilities such as lymphoma.
Given the predilection of this disease to the chest, the lung and mediastinal lymph nodes
are the most common sites for biopsy. Bronchoscopic samples are often obtained initially
given their good sensitivity for this disease and low complication rates. If the diagnosis
of sarcoidosis is not confirmed by bronchoscopy, more invasive surgical procedures such as
mediastinoscopy or open lung biopsy may be required. As such, any improvement in the
minimally invasive methods for diagnosis of this condition would be of benefit these
patients and may also lead to cost efficiencies for the health care system.
Transbronchial needle aspiration (TBNA) with a 19 gauge "histology" needle has been the
standard bronchoscopic approach to the biopsy of mediastinal lymph nodes in patients with
suspected sarcoidosis. Using anatomical landmarks and computed tomography (CT) images, the
TBNA needle is advanced "blindly" through the airway wall, and into the mediastinal lymph
node. Because of the lack of real-time visual guidance, it is possible to miss the targeted
lymph node as well as enter vascular structures with the needle system and cause bleeding.
A new method of performing TBNA has now been developed which uses real-time endobronchial
ultrasonography to advance a 22 gauge needle into mediastinal lymph nodes under direct
visualization (EBUS-TBNA). While this technique has been proven to be effective in the
diagnosis and staging of lung malignancy, its sensitivity for the diagnosis of sarcoidosis
is unclear given that larger biopsy samples are often required to make this diagnosis.
This study will aim to randomize patients with a clinical suspicion of sarcoidosis and
mediastinal adenopathy undergoing bronchoscopy to TBNA vs. EBUS-TBNA in order to compare the
sensitivity of these tests for sarcoidosis.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04008069 -
Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis
|
Phase 2 | |
Recruiting |
NCT02807025 -
Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases
|
N/A | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT00274352 -
A Study of Adalimumab to Treat Sarcoidosis of the Skin
|
Phase 2 | |
Completed |
NCT00326534 -
Rickettsial Genesis to Sarcoidosis in Denmark
|
N/A | |
Recruiting |
NCT00470327 -
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
|
||
Completed |
NCT00512967 -
The Occurence of Inflammation and Oxidative Stress in Lung Diseases
|
N/A | |
Recruiting |
NCT01745237 -
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
|
||
Completed |
NCT00369980 -
Diagnostic Usefulness of Fluorine–18-α–Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient
|
N/A | |
Completed |
NCT00379275 -
Eye and Immunogenetic Features of Sarcoidosis
|
N/A | |
Completed |
NCT00366509 -
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
|
||
Completed |
NCT06396910 -
TB and Sarcoidosis Granuloma
|
||
Completed |
NCT04156789 -
Obstructive Sleep Apnoea in Sarcoidosis
|
||
Recruiting |
NCT02916459 -
EBUS-TBNA vs Flex 19G EBUS-TBNA
|
N/A | |
Recruiting |
NCT02827734 -
Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)
|
||
Completed |
NCT02546388 -
Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis
|
N/A | |
Completed |
NCT01687517 -
Efficacy and Safety of Influenza Vaccine During Sarcoidosis
|
Phase 3 | |
Completed |
NCT01139710 -
Sarcoidosis-associated Pulmonary Hypertension
|
N/A | |
Terminated |
NCT00747461 -
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
|
Phase 4 | |
Completed |
NCT00555347 -
Use of Armodafinil for Fatigue in Sarcoidosis
|
Phase 2/Phase 3 |